Skip to content

Effectiveness of currently available cardiac rehabilitation programmes from 8 European institutes in elderly patients.

The (cost) effectiveness, sustainability and participation levels of current EUropean Cardiac Rehabilitation programmes in Elderly: a prospective cohort study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21225
Enrollment
1760
Registered
2015-07-16
Start date
2015-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac rehabilitation

Interventions

Not applicable.

Sponsors

Isala Zwolle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Patients of 65 years or older who have accepted CR - Signed written informed consent - One of the following criteria: o Patients with an ACS, including MI and/or revascularisation within 3 months prior to the start of the CR programme o Patients that underwent a PCI within 3 months prior to the start of the CR programme o Patients that received CABG within 3 months prior to the start of the CR programme o Patients who were treated surgically or percutaneously for valvular heart disease (including TAVI) within 3 months prior to the start of the CR programme o Patients with a stable angina with documented significant CAD (defined by standard non-invasive or invasive methods)

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Contraindication to CR - Mental impairment leading to inability to cooperate - Severe impaired ability to exercise - Signs of severe cardiac ischemia and/or a positive exercise testing on severe cardiac ischemia - Insufficient knowledge of the native language - Implanted cardiac device (CRT-P, ICD)

Design outcomes

Primary

MeasureTime frame
Difference in peak oxygen uptake (VO2peak) between the end of CR programme (T1) and baseline (T0).

Secondary

MeasureTime frame
- Difference in VO2peak between 12 months (T2) and T0 - Difference in VO2peak between T2 and T1 - Traditional risk factors for CVD - Major Adverse Cardiovascular Events (MACE) - General health - Care utilisation - Costs of care utilisation - Adherence - Compliance

Contacts

Public ContactLeonie Prins

Diagram B.V.

l.prins@diagram-zwolle.nlTel: +31 (38)4262999

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)